Direkt zum Inhalt
Merck
  • Anti-tubercular agents. Part IV: Synthesis and antimycobacterial evaluation of nitroheterocyclic-based 1,2,4-benzothiadiazines.

Anti-tubercular agents. Part IV: Synthesis and antimycobacterial evaluation of nitroheterocyclic-based 1,2,4-benzothiadiazines.

Bioorganic & medicinal chemistry letters (2007-08-19)
Ahmed Kamal, S Kaleem Ahmed, K Srinivasa Reddy, M Naseer A Khan, Rajesh V C R N C Shetty, B Siddhardha, U S N Murthy, Inshad Ali Khan, Manoj Kumar, Sandeep Sharma, Anshu Beulah Ram
ZUSAMMENFASSUNG

In continuation of our earlier work on benzothiadiazines, we have prepared a series of nitrofuran, nitrothiophene and arylfuran coupled benzothiadiazines and evaluated them for antimycobacterial and antibacterial activities. One of the compounds 2f has shown good in vitro antimycobacterial activity. All the synthesized compounds have shown moderate to good antibacterial activity.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Rifampicin, ≥95% (HPLC), powder or crystals
Sigma-Aldrich
Rifampicin, suitable for plant cell culture, BioReagent, ≥95% (HPLC), powder or crystals
Supelco
Isoniazid, analytical standard, ≥99% (TLC)
Sigma-Aldrich
Nitrofurantoin, 98.0-102.0% (EP, UV), meets EP testing specifications
Supelco
Nitrofurantoin, VETRANAL®, analytical standard